Conventional PET/CT scanners with standard axial field-ofview (SAFOV) usually cover around 23-26 cm [1,2]. Over the last decade, however, there has been tremendous effort in the development of long axial field-of-view (LAFOV) PET/ CT scanners, and several of them have entered the clinical arena [3][4][5]. It is well recognized that, with LAFOV PET/ CT scanners, one could image better (e.g. reconstruct at higher resolution and detect smaller lesions), image faster, image longer after tracer injection, and image gently (e.g., at a much lower radiopharmaceutical dose than usual, which will enable more PET scans in the children population, as well as more repeated scans in the adult population) [1].In the July issue of European Journal of Nuclear Medicine and Molecular Imaging, a superbly designed and executed study on the first clinical implementation of a LAFOV PET/CT scanner was reported by Dr. Rominger and colleagues from Bern University Hospital, University of Bern, Switzerland [5]. This is a prospective, nonrandomized, dual-arm crossover, comparative imaging study with a clearly stated hypothesis and inclusion/exclusion criteria. The number of patients needed for the study (> 40) was calculated to provide robust statistical analysis. In addition, three PET tracers ( 18 F-FDG, 18 F-PSMA-1007, and 68 Ga-DOTA-TOC) and 2 PET isotopes ( 18 F and 68 Ga)This article is part of the Topical Collection on Technology.